PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Selected for Major OA Conference Presentations, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,752 Posts.
    lightbulb Created with Sketch. 1907
    This is every bit as valid as anything I wrote about above. I've often seen HC as a contrarian indicator in the past, and here I am now being that emotional retailer i've sought to be better than. It still all comes down to deals though, in my opinion. If the next $30m through the doors comes from a non-dilutive source, then we have a heartbeat. If it comes from 150,000,000 shares added at $0.20 then prospects obviously get darker and darker from there. None of us know how this is going to play out. We all have inklings built on hopes and fears, trust and doubt. It could definitely go how Bedger suggests, rather than the nightmarish scenario i've laid out. Obviously nothing is advice, and anyone would be mental to act on any retailer commentary they've read on HC.

    As i've said before, i'm not selling, but i'm not tempted to buy right now either. My gut says more price weakness ahead as cash dwindles and frankly....who is going to believe any talk about proximate deals from these guys now? I'll believe a deal is happening when I see the money in the bank, and I doubt i'm alone in that. Maybe 2mg dosing confirmation will give the price a bounce before that - don't know. Quite possibly. I do agree that it is currently, more or less, priced to fail. That may well make this a ridiculously good opportunity, if it subsequently doesn't. Good post Bedger.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.